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As we sit down to write about the evolving relationship between 
embryology, cell biology and human genetics at the University of Cape 
Town, it strikes us as most apposite that we are sitting in an office, 
now part of the Division of Cell Biology, that was once a small library 
in the Department of Human Genetics, a space set aside by Prof. Peter 
Beighton, the Head of Department, as a place to read, think and write. 
In the 1980s, the Department of Human Genetics occupied a floor (now 
called level 3) of the Anatomy Building, as well as this library and a 
small suite on level 6, which housed the office of the Head of Department 
and his clinical and administrative staff. The Department of Anatomy, 
headed by Prof. Benjamin Rawdon, occupied a number of other floors 
in the building. Anatomy was one of the founding departments in the 
faculty, having being established in 1912 at the Hiddingh campus, then 
moving to the Werner and Beit Buildings in 1929.[1] The move to the 
Anatomy Building took place in the 1970s, when human anatomy and 
human embryology were taught largely as descriptive subjects. In the 
1980s, as genetics began to take centre stage in the world of the biological 
sciences, anatomy departments were also modernising, embracing the 
disciplines of cell biology, developmental biology and anthropology into 
their fold and innovating with respect to how anatomy was being taught. 
In keeping with this trend, in the late 1980s, the Faculty of Medicine (now 
Health Sciences) sought to advance and enliven the teaching of histology, 
embryology and cell biology and to grow the research capacity in the 
anatomy department. The Department of Anatomy and Cell Biology was 
thus created, and three cell and developmental biologists were appointed: 
Prof. Benjamin Rawdon, Dr Susan Kidson and Dr Callie Els. It was most 
fortuitous that these new arrivals could benefit from being in the physical 
and academic proximity of the dynamic Department of Human Genetics 
led by Prof. Beighton.
Reflecting on the origins of 
embryology and genetics
Toward the end of the 19th century, Wilson, Morgan and Boveri, 
part of a group called ‘physiological embryologists’ were seeking to 
understand whether the elements of inheritance were to be found 
in the nucleus or the cytoplasm. By studying the chromosomes 
of sea urchins, Morgan was eventually able to provide material 
evidence for the concept of a gene.[2] Although this type of genetics 
was originally seen as being part of embryology in the 1930s, 
genetics became a subject of its own, and hostilities between 
embryologists and geneticists began to emerge. The re-synthesis 
of genetics and embryology did not come easily, but a merger was 
achieved in the late 1960s when embryologists, cell biologists and 
geneticists came together in what became known as developmental 
genetics. These changes were timely, because many other biological 
revolutions were underway and new subjects had arisen: a synthesis 
of evolution, genetics and development resulted in the rise of the 
discipline EvoDevo, and powerful bioinformatics tools fuelled the 
genomics fire, all of which significantly advanced the discipline of 
developmental genetics.[2]
The stage was thus well set for cell biologists and human geneticists 
at the University of Cape Town (UCT) to work closely together. 
With common interests in genes, molecular biology and medical 
embryology, three staff members, Profs Raj Ramesar, Jacquie 
Greenberg (both in Human Genetics) and Susan Kidson (Cell 
Biology) saw the need for a joint honours programme, and this 
was launched in 1998. The academic and organisational success 
of this joint exercise soon led to a programme of greater expanse, 
culminating in the current ‘Joint Honours Programme’ which 
includes human genetics, forensic genetics, medical cell biology, 
medical biochemistry, immunology, microbiology and virology, 
physiology, radiobiology and structural biology.
Research collaborations between 
human genetics and cell biology
A common interest in eye development and inherited blinding 
conditions (and the potential of gene therapy) led to genetic and 
cellular studies of the retina.[3] There was minimal evidence at the 
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time that some inherited blinding conditions result from a primary 
insult to the retinal pigment epithelium (RPE) and not to the neural 
retina, as had been shown for other blinding conditions. But the 
decision to work on the RPE has been fortunate and productive. 
Prof. Raj Ramesar and cell biologist Prof. Sharon Prince have 
recently worked together on a mutation in the signal sequence of 
the carbonic anhydrase IV (CAIV) gene in an autosomal dominant 
form of retinitis pigmentosa (RP17 locus).[4] The role of the RPE 
in spinocerebellar ataxia type 7 (SCA7) is currently being explored 
(Ms Sylvia Kamanzi-wa, Dr Robea Ballo and Profs Kidson and 
Greenberg). 
The cloning of Dolly the sheep in 1997[5] led to an unprecedented 
worldwide rise in levels of interest in embryos and genetics, and 
for the next 10 years or more we were kept well occupied by the 
press, the public and the scientific community, explaining what 
can and what cannot (or should not) be cloned, and what the 
moral, legal and ethical implications might be. Profs Kidson and 
Greenberg joined with a group of South African (SA) scientists, 
including Prof. Michael Pepper (University of Pretoria) and Prof. 
Ames Dhai (University of the Witwatersrand), who were tasked 
with crafting legal regulations to control human cloning (as well 
as stem cell research and therapy) in SA. During the same period, 
an international team of developmental cell biologists[6] finally 
succeeded in culturing human embryonic stem cells (the inner cell 
mass of a blastocyst embryo) and were able to prove that they were 
pluripotent and able to differentiate into many different cell types 
of the body in vitro. The tidal wave of interest in stem cell biology, 
gene therapy and regenerative medicine rose to yet higher levels. 
As the storm broke, extraordinary claims hit the air: stem cells in 
all their many guises were revealed, and the extraordinary potential 
for research, drug discovery and therapy was announced. Many 
discoveries and claims have given rise to some of the most vexing 
biomedical and ethical issues ever faced by scientific and medical 
experts, the public and law makers. The storm has been further 
fuelled by other winds of scientific and technological change, with 
advances in molecular genetics, genomics, proteomics and imaging 
paving the way for ever more informative studies.
The UCT Stem Cell Initiative and the 
new era
What is so seductive about stem cells? It is the ease with which 
they can be harvested, their immortal state and their ability to 
differentiate into many of the cell types of the body. It was Dr Janine 
Scholefield,[7] originally trained by Prof. Jacquie Greenberg in Human 
Genetics, and at the time working at the University of Oxford, who 
brought our attention to the new cells on the block, namely induced 
pluripotent stem cells (iPSC).[8,9] It was evident to us that the time 
was ripe to set up a stem cell research facility at UCT.[10] Dr Robea 
Ballo, also originally from the Department of Human Genetics 
(in the 1980s) was invited to join the group and establish the iPSC 
facility. She spent time in the laboratories of two collaborators at the 
University of Oxford (Dr Sally Cowley and Prof. Matthew Wood), 
where she developed her expertise in generating iPSCs. She returned 
to UCT in 2013 to manage the UCT stem cell facility. iPSC work 
is routinely conducted in the UCT facility and the technology has 
been and is currently the basis of a number of PhD theses in both 
human genetics (Dr Lauren Watson and Dr Danielle Smith) and cell 
biology (Ms Dimakatso Gumede and Ms Sylvia Kamanzi-wa). iPSC 
technology is time consuming and technically demanding, but the 
main challenge to any time-constrained student is to find a way to 
set up authentic disease models. Perhaps the most important of these 
is the ability to identify the tissues that are critical for modelling the 
disease in a culture dish and which would ultimately help define the 
physiological phenotype being investigated. Thus far, the spectrum 
of cells that have been generated by our students have been neurons, 
photoreceptors, mesenchymal cells, adipocytes and retinal pigment 
epithelium for conditions such as spinocerebellar ataxia type 7[10] and 
hereditary familial poikiloderma.[11]
As the world turns its attention to new advances in genome 
engineering, so too have we, with the latest gene-editing technology, 
clustered regularly interspaced short palindromic repeats (CRISPR/
Cas9), coming firmly into our field of view. The technology is cost 
effective, uncomplicated and is able to permanently and selectively 
edit DNA.[12] The CRISPR/Cas9 system is modelled on a viral 
defence system of microorganisms in which a pair of small RNA 
‘molecule scissors’, as it were, are designed to a specific target site 
on double-stranded DNA. The RNA molecule is complementary 
to the DNA target and can be devised to find a binding site on 
any gene of interest. The simplicity of the CRISPR/Cas9 system 
has made it possible for researchers to edit mammalian genes 
in a range of different cells, thereby opening up the potential to 
investigate genetic diseases. The UCT Stem Cell Initiative team 
is currently attempting to use the CRISPR/Cas9 in iPSCs derived 
from patients who suffer from an autosomal dominantly inherited 
form of SCA7, a blinding and movement disorder. SCA7 is caused 
by a dynamic and unstable genetic expansion in the ATXN7 gene. [10] 
The ultimate objective is to generate isogenic lines that will allow 
us to define the molecular phenotype of the condition. Ultimately, 
the consideration would be to refine the previous locally developed 
gene-silencing form of therapy by our ataxia and stem cell group 
for the treatment of this specific form of inherited ataxia.[7] Other 
projects underway include the generation of isogenic lines from 
iPSCs generated from South African patients with an autosomal 
dominant form of hereditary fibrosing poikiloderma (collaboration 
with Prof. Bongani Mayosi) and tissue engineering of the corneal 
endothelium. 
We look forward to the next era of biological medicine and science, 
where gene therapy and stem cell biology come of age.
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